Forge Therapeutics Gets up to $11.1M to Advance ?Superbug? Drugs

As strains of bacteria evolve to fight back against common antibiotics, a slew of biotechnology companies are working to develop ways to combat these ?superbugs.? San Diego?s Forge Therapeutics is among those targeting gram-negative bacteria, a type of bacteria that has a protective outer membrane that makes it especially resistant to drugs. Comparatively, gram-positive bacteria [?]